Ipamorelin 10mg

For Research Purposes Only. Not intended for human consumption.

Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist consisting of 5 amino acids. First developed in the late 1990s, Ipamorelin is notable for its high selectivity — it stimulates growth hormone release with minimal impact on cortisol, prolactin, or ACTH levels compared to other GH secretagogues, making it a valuable research tool for studying isolated GH pathway effects.

Research Overview

Ipamorelin research has focused on its selective GH secretagogue profile, pharmacokinetic characteristics, and effects on body composition parameters in preclinical models. It is frequently studied in combination with CJC-1295 DAC due to complementary mechanisms producing synergistic GH secretion in research models.

Key Research Areas

• Selective growth hormone secretagogue mechanisms
• Ghrelin receptor pharmacology
• Body composition and lean tissue research models
• Bone density research in preclinical models
• Combined GHRH/ghrelin pathway research

Product Specifications

• Form: Lyophilized powder
• Purity: ≥99% (HPLC verified)
• Quantity: 10mg per vial
• Testing: Independent third-party COA available
• Storage: Store at -20°C. Stable at 4°C short-term.
• CAS Number: 170851-70-4

For laboratory research purposes only. Not approved for human or veterinary use.

The information provided here is for educational and research purposes only. All studies referenced are preclinical or in vitro unless otherwise noted. This product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any condition.

Researchers should review all available literature and consult appropriate regulatory guidelines before use. Certificate of Analysis documents for each lot are available in our COA Library.